Prescription medication · Penicillinase-Resistant Penicillin
dicloxacillin
Also sold as Dynapen. Dicloxacillin treats infections caused by certain staph bacteria that are resistant to penicillin.
Data updated 2026-05-15
- 178
- FDA reportsRarely reported
- 3
- InteractionsFew interactions
- $0.46
- Generic price (NADAC)
What the data shows
dicloxacillin (Dynapen) is a prescription Penicillinase-Resistant Penicillin, among the least-reported drugs the FDA tracks (178 FDA reports), with 3 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
dicloxacillin (Dynapen) is a prescription Penicillinase-Resistant Penicillin. Dicloxacillin treats infections caused by certain staph bacteria that are resistant to penicillin.
Dicloxacillin is an antibiotic that fights bacteria in your body. It belongs to a class of drugs called penicillinase-resistant penicillins.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.46/unit
Generic Available
Yes (2 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Dicloxacillin treats infections caused by certain staph bacteria that are resistant to penicillin.
Common side effects
Nausea, Vomiting, Diarrhea
Key warnings
Taking dicloxacillin with too little water or right before bed can cause burning, inflammation, or ulcers in your esophagus.
The sections below are summarized in plain English from dicloxacillin's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Dicloxacillin works by stopping the growth of bacteria. It does this by interfering with the bacteria's ability to form cell walls. This weakens the bacteria and eventually kills them.
Side Effects (from patient reports)
Based on 178 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for dicloxacillin, by number of reports
- Suspected Transmission Of An Infectious Agent Via Product
Suspected Transmission Of An Infectious Agent Via Product
13 reports
- Rash
Rash
12 reports
- Fatigue
Fatigue
11 reports
- Pruritus
Pruritus
11 reports
- Abdominal Discomfort
Abdominal Discomfort
9 reports
- Back Pain
Back Pain
8 reports
- Diarrhoea
Diarrhoea
8 reports
- Drug Hypersensitivity
Drug Hypersensitivity
8 reports
- Dyspnoea
Dyspnoea
8 reports
- Headache
Headache
8 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for dicloxacillin each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where dicloxacillin sits
dicloxacillin has more FDA adverse-event reports than 1% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is dicloxacillin; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 178 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
178
Reports Mentioning Death
20
11.2% of reports — not proof of cause
Hospitalization Reports
69
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT | 13 |
| 2 | RASH | 12 |
| 3 | FATIGUE | 11 |
| 4 | PRURITUS | 11 |
| 6 | ABDOMINAL DISCOMFORT | 9 |
| 8 | BACK PAIN | 8 |
| 9 | DIARRHOEA | 8 |
| 10 | DRUG HYPERSENSITIVITY | 8 |
| 11 | DYSPNOEA | 8 |
| 12 | HEADACHE | 8 |
| 13 | NAUSEA | 8 |
| 14 | ACUTE KIDNEY INJURY | 7 |
| 15 | DEATH | 7 |
| 16 | HYPERSENSITIVITY | 7 |
| 17 | STAPHYLOCOCCAL INFECTION | 7 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Taking dicloxacillin with too little water or right before bed can cause burning, inflammation, or ulcers in your esophagus.
Known Drug Interactions
Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin.
Mechanism: Dicloxacillin can make warfarin less effective at thinning the blood.
Drug Interactions Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
Mechanism: Tetracycline stops bacteria from growing, which can prevent dicloxacillin from killing the bacteria effectively.
Probenecid administered concomitantly with penicillins increases and prolongs serum penicillin levels (see DOSAGE AND ADMINISTRATION ).
Mechanism: Probenecid slows down how fast the body gets rid of dicloxacillin, causing the drug to stay in the blood longer.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take dicloxacillin with food?
What should I do if I experience side effects?
Can I take dicloxacillin if I am allergic to penicillin?
How long should I take dicloxacillin?
Can dicloxacillin interact with other medications?
What is the usual dose of dicloxacillin for adults?
What is the usual dose of dicloxacillin for children?
What should I do if I think I have taken too much dicloxacillin?
Can dicloxacillin cause diarrhea?
Is it safe to drive or operate machinery while taking dicloxacillin?
What are the common side effects of dicloxacillin?
Does dicloxacillin interact with other medications?
What drug class is dicloxacillin?
What pregnancy or breastfeeding source fields are listed for dicloxacillin?
Related Medications in Penicillinase-Resistant Penicillin
Other drugs grouped near dicloxacillin - same-class peers and common alternatives.
amikacin
Amikin
Amikacin is an antibiotic medicine.
Compare with dicloxacillin →
amoxicillin
Amoxil
Amoxicillin and Clavulanate Potassium is a combination medicine used to fight bacterial infections.
Compare with dicloxacillin →
amoxicillin/clavulanate
Augmentin
Augmentin is a combination of two medicines, amoxicillin and clavulanate.
Compare with dicloxacillin →
ampicillin/sulbactam
Unasyn
Unasyn is a combination of two antibiotics that fights bacteria in your body.
Compare with dicloxacillin →
azithromycin
Zithromax, Z-Pack
Azithromycin is an antibiotic that fights bacteria.
Compare with dicloxacillin →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for dicloxacillin: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 178.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 11.24%.
- terazosin Δ 0.01 pts · 7,436 reports · Alpha-1 Blocker 11.24%death share
- zaleplon Δ 0.01 pts · 1,538 reports · Non-Benzodiazepine Hypnotic (Z-Drug) 11.25%death share
- pantoprazole Δ 0.02 pts · 240,800 reports · Proton Pump Inhibitor (PPI) 11.25%death share
- metronidazole topical Δ 0.04 pts · 45,816 reports · Topical Antibiotic (Rosacea) 11.28%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on dicloxacillin
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for dicloxacillin
The FDA label for dicloxacillin (sold under brand names such as Dynapen) classifies it as a prescription-only medication in the Penicillinase-Resistant Penicillin class. Dicloxacillin treats infections caused by certain staph bacteria that are resistant to penicillin. Official labeling lists 5 commonly reported side effects, including Nausea, Vomiting, Diarrhea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 178 voluntary reports. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.46.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: October 15, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages